In this week’s video, Dr. Brian Durie discusses the value of ASCT even with the use of newer drug regimens. BOTTOM LINE: We still value high-dose melphalan with ASCT in 2017. Have a question? Submit it to AskDrDurie@myeloma.org IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@...
MarWatch CNN Interview Highlighting IMF-Funded Myeloma Research Project in Iceland
In the latest episode of “Vital Signs,” CNN Chief Medical Correspondent Dr. Sanjay Gupta travels to Iceland, where he interviews International Myeloma Foundation Chairman Dr. Brian Durie and(...)
FebWhat is the latest on the Black Swan Research Initiative?
Made up of an exciting team of multinational researchers, the Black Swan Research Initiative® team has developed a way to monitor the status of myeloma at very low levels, or minimal residual disease(...)
iStopMM is part of the Black Swan Research Initiative’s goal to find a cure for myeloma.” What does iStopMM stand for? I is for Iceland, the country. S is for Screens. T is for Treats. O is for or.(...)
JulIMF’s Black Swan Research Initiative®: ASCENT Trial
Dr. Shaji Kumar of the Mayo Clinic in Rochester, Minnesota, discusses the exciting new Black Swan Research Initiative® clinical trial: ASCENT, which stands for Aggressive Smoldering Cure Evaluating(...)
JulBlack Swan Research Initiative
Understanding that the search for a cure for multiple myeloma demands constant innovation, the IMF has launched the Black Swan Research Initiative®, a unique project to develop the first definitive(...)
JuliStopMM (Iceland Screens, Treats, or Prevents Multiple Myeloma)
In this video, Dr. Sigurdur Kristinsson of the University of Iceland describes the exciting new Black Swan Research Initiative® study, iStopMM (Iceland Screens, Treats, or Prevents Multiple Myeloma(...)